Amphastar Pharmaceuticals, Inc. (AMPH)
Pharmaceutical Preparations
Latest Price
$19.94
TTM P/E
12.01
Normalized P/E
8.97
Div Yield
--
Book Value
17.06
P/B Ratio
1.17
Valuation metrics
adjust assumptions →EPS: $2.03
Book value / share: $17.28
Formula: √(22.5 × EPS × BVPS)
Graham Number
$28.09
+41% upside
Norm. op. income: $107M (median of 7yr)
Tax rate: 21%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$11.55
42% downside
Base FCF: $121M (median of recent 5yr)
Growth: 22%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$149.57
+650% upside
EPS: $2.03
Target P/E: 9×
Formula: EPS × P/E
P/E Fair Value
$18.27
8% downside
Institutional Ownership
68.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.42M | $106.0M | 12.15% | -40.7K | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 2.03M | $39.0M | 4.54% | +228.3K | 2026-03-31 |
| STATE STREET CORP | 1.61M | $31.0M | 3.60% | +75.7K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.54M | $30.0M | 3.46% | -- | 2026-03-31 |
| TD Asset Management Inc | 1.54M | $30.0M | 3.45% | -422.0K | 2026-03-31 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.40M | $27.0M | 3.13% | +676 | 2026-03-31 |
| MARSHALL WACE, LLP | 1.03M | $20.0M | 2.30% | -211.6K | 2026-03-31 |
| AMERICAN CENTURY COMPANIES INC | 1.02M | $19.0M | 2.28% | +352.2K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 976.6K | $19.0M | 2.19% | +89.8K | 2026-03-31 |
| Epoch Investment Partners, Inc. | 898.9K | $17.0M | 2.01% | -227.7K | 2026-03-31 |